School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

IDEAYA Biosciences Inc IDYA

Healthcare · Biotechnology

$36.11last close 2026-10-09 · market cap $3.48B · delayed data

Trailing returns

1M-5.84%
3M-3.14%
6M+16.48%
1Y+34.79%
5Y+41.16%

Basis: Adjusted daily closes.

What it does

IDEAYA Biosciences, Inc., a precision medicine oncology company, develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States.

Open IDYA in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies